The Department of Dermatology’s staff and surgeons are at the forefront of the field, offering personal consultation and guidance to each patient. Continued research and state-of-the-art technology enables BMC’s physicians to develop more effective and less invasive techniques for treatments. We care for adult and pediatric patients providing the following treatments as appropriate:

[view name="treatmentsembed" arg="859"][/view]

[view name="treatmentsembed" arg="872"][/view]

[view name="treatmentsembed" arg="888"][/view]

[view name="treatmentsembed" arg="889"][/view]

[view name="treatmentsembed" arg="924"][/view]

[view name="treatmentsembed" arg="928"][/view]

[view name="treatmentsembed" arg="941"][/view]

Learn More about Mohs Surgery >

[view name="treatmentsembed" arg="958"][/view]

[view name="treatmentsembed" arg="985"][/view]

[view name="treatmentsembed" arg="1005"][/view]

For cosmetic dermatology services, visit the Boston University Cosmetic and Laser Center.

Treatment Cure Rates

Clinical studies demonstrate that Mohs micrographic surgery provides five-year cure rates of approximately 99% for primary basal cell carcinomas, and 96% for recurrent basal cell carcinoma. Cure rates for squamous cell carcinoma are approximately 97%.These cure rates are significantly higher than with other methods of tumor removal or destruction.

Mohs surgery is preferred over other treatments for:

  • Tumors on the face
  • Tumors on other body sites that may be difficult to repair if too much tissue is removed
  • Recurrent (previously treated) tumors
  • Large tumors or tumors without clearly defined edges
  • Tumors that appear aggressive under the microscope